Since semaglutide encourages your pancreas to release insulin, the hormone that lowers blood sugar, it can leave you at risk of hypoglycemia
Tirzepatide shows a flatter nausea-dose curve (nausea does not markedly increase from 5 mg to 15 mg), while semaglutide shows a steeper dose-response for nausea
You should contact your GP if you experience persistent diarrhoea lasting more than 7 days, or sooner if accompanied by blood, fever, or signs of dehydration
A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products
Chen, W., Zhang, S., Yu, Y., Zhang, H
Built on radical transparency and fiduciary alignment, we empower employers to take control of their pharmacy spend and experience with our 100% pass-through model.